🔗 Visit the ClinicalTrials.gov page for NCT00294671
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. | JAMA | 2013 | 1.69 |
| 2 | Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity. | Sci Transl Med | 2011 | 1.62 |
| 3 | Transthyretin (TTR) cardiac amyloidosis. | Circulation | 2012 | 1.40 |
| 4 | Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. | Haematologica | 2012 | 1.19 |
| 5 | Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. | PLoS One | 2009 | 0.87 |
| 6 | Nuclear imaging modalities for cardiac amyloidosis. | J Nucl Cardiol | 2014 | 0.77 |
| 7 | Transthyretin Val30Met mutation in an African American with cardiac amyloidosis. | Congest Heart Fail | 2010 | 0.75 |